Cargando…
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer
The safety of oncolytic adenovirus-mediated suicide and interleukin-12 (IL12) gene therapy was evaluated in metastatic pancreatic cancer patients. In this phase I study, a replication-competent adenovirus (Ad5-yCD/mutTK(SR39)rep-hIL-12) expressing yCD/mutTK(SR39) (yeast cytidine deaminase/mutant S39...
Autores principales: | Barton, Kenneth N., Siddiqui, Farzan, Pompa, Robert, Freytag, Svend O., Khan, Gazala, Dobrosotskaya, Irina, Ajlouni, Munther, Zhang, Yingshu, Cheng, Jingfang, Movsas, Benjamin, Kwon, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851493/ https://www.ncbi.nlm.nih.gov/pubmed/33575474 http://dx.doi.org/10.1016/j.omto.2020.11.006 |
Ejemplares similares
-
Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer
por: Freytag, Svend O, et al.
Publicado: (2015) -
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma
por: Nyati, Shyam, et al.
Publicado: (2023) -
Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors
por: Gibson, Heather, et al.
Publicado: (2015) -
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health
por: Thoidingjam, Shivani, et al.
Publicado: (2023) -
NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
por: Leung, Elaine Y.L., et al.
Publicado: (2020)